Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Senseonics Holdings, Inc. (SENS)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
1.0600+0.0400 (+3.92%)
At close: 04:00PM EDT
1.0300 -0.03 (-2.83%)
After hours: 07:56PM EDT
Advertisement
Sign in to post a message.
  • R
    RichardP
    Time and patience this is going to be a great device for millions and millions of people.

    Sens
  • R
    Rich
    Dexcom fluctuated up and down between $20 for five years before it started taking off. Word will spread, patients will want the best technology, doctors will get on board, heavy marketing and sales will follow.
  • M
    Mr
    You buy companies that will grow and make money...This is one of such.. Marketing and sales,sales sales will fire this up in few years to come..Ain't selling by any chance!
  • T
    Trader Nick 44
    People, there's a reason that I have started posting here again. I have many thousands of shares.
    I am a technical trader.
    QQ for the technicians; Where is all the volume? Why has it dried up?
    I'll leave it at that.
  • D
    DC
    dxcm just split 4to1. now total shares about equal with both companies.
  • R
    Rich
    Day 7 of my E3. Accuracy is amazing. Knowing that I don’t have to change sensors every 10 days is huge. Unlike Dexcom, no issues with adhesive, skin irritation, or sensor peeling off. Still getting used to all the app features. Love the on arm vibration alerts.
  • M
    Michael
    The future is bright!
    Bullish
  • G
    Glyen
    However frustrating the last 18 months has been in this stock, along with the concern and worry about the company marketing strategy. Being in other diabeties/eversense forums gives me hope. There is very little negative feedback about the product, 99% positive. There must be something in that, right?
  • j
    jack
    Boys and girls, slowly but surely. As an example end of July SENS is 115-220. Slowly ascend just be patient.
    Bullish
  • R
    Rich
    Just had the Eversense 180 insertion completed on Tuesday. 15 minute procedure, 2.5 day “warm-up” period and it’s amazing.

    No pain or problems with insertion. Doctor was great. Eversense support team has been fantastic.

    Currently wearing my Dexcom as well until it expires tomorrow. When compared to finger stick testing, Eversense is much more accurate. Dexcom seems to be on a 10 delay, where as Eversense is operating in real-time.

    Plus no more skin irritations, no need to change every 10 days. So far it’s all been a great experience.
  • E
    Eddie
    sens will be great after this bear market is done
    Bullish
  • H
    Hong Lai
    @Rome, @Takecares please make your SENS advertising to diabetic community, not in this board. We're all abord and can't get off at this moment. Thanks.
  • C
    Christophe
    Everyone who did not know we were going to lose all of yesterdays's gains doesn't know this stock very well. Still hoping for improvement though
  • E
    Eddy
    Guys join the eversense Facebook page and witness yourself how this product changes lives of people with diabetics, you will know this thing will go diabolical eventually..sooner or later..forget about share price for a moment man...look LONG term..
  • M
    Mike
    I have over 32k shares im going hold for 10 years
  • F
    Flappington
    Another red day across the market. Well, what can you do? Lean times, don't take on any new debt, build the savings, and keep investing with any extra funds after that. This will all pass eventually once the Federal Reserve gets out of the way.
  • R
    Ricky
    This things going 10 dollars next summer
  • T
    Trader Nick 44
    Update from Fintel, (I am not a subscriber, so I don't know their time delay on the data) Short Interest Ratio, 43.30 Days to Cover.

    My previous post from yesterday;

    From Fintel - Short Interest Ratio, 39.35 Days to Cover

    Days to cover continuing to rise. That's a deep hole.

    Today's hole is even deeper.
    It won't take much to spark an upswing. Everyday they're borrowing more to push/hold it down.

    We all know there's a lot of share's outstanding. Maybe those questioning this data should tell Fintel, I'm sure they'll be interested in your super duper important share count information.
  • T
    Trader Nick 44
    J. K. and HC, same person.
  • R
    Rome
    " Quoted from Stockwits" :
    Scotish-noble1 :
    My Personal Experience With #SENS' Competitors :

    I have been thinking about writing a post about this for a while now. Hopefully, reading this will not be a waste of your time.
    I am not a financial advisor. And this is not financial advice. But I do have first-hand experience using two CGMs you have likely heard of : Dexcom G6 and Libre Freestyle.  I am 34 years old, Type 1 diabetic, diagnosed 5 years ago at the very late/strange age of 29. I have no family history and doctors cannot yet explain why I am Type 1. Most likely they (and I) will never know. 
    Last night, I was using both sensors to monitor which one I liked better.  (The Libre II has just been released and I was excited about it, although it is not yet compatible with an iPhone/smart device). In short, after scanning Libre on the reader, I received a "low" before bed -- so I did I blood test. Annoyingly, the reading was over 150 mg/DL *off*. The device read 82, but it was really 240 according to the finger stick. Glad I didn't "correct" without checking. Equally bad, the Dexcom G6 inexplicably stopped working (7 days in) in the middle of the night -- beeping incessantly and unable to offer readings.  While throughout the day I was receiving intermittent error messages such as "wait three hours for device to reconnect" -- if you use Dexcom, you likely know what I'm talking about -- the sensor eventually failed.I received a message on the app that essentially read: "Please remove and insert new sensor." It was my last one until I reorder. In the end, I removed both sensors this morning, well before their advertised expiration dates. 
    (FWIW, and to their credit, I called both companies and both agreed to replace the sensors for free).
    Why do I tell this story? One of the things that impresses me most with the latest #sens earnings call---- and the company in general -- is its commitment to accuracy (and duration) above all else. This in my very humble opinion is where the competition in the CGM market does not have a monopoly.  I have been constantly let down by these 10 and 14 day sensors, which are often inaccurate, fall off, need to be changed, or do not work as advertised or marketed.  While using these devices is life-changing -- and certainly better than nothing -- if $sens can deliver a new product that is reliable and accurate and long-lasting...I'm all in. There is room for much technological advancement in the CGM space IMO. Hopefully, #sens can fill that void. 
    I currently own 6,550 shares at $2.59.
    ///"Quotes end "

    🤠👉I believe SENS must be real game changer for all Diabetes patients!!!
Advertisement
Advertisement